J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer Post author:Sam Post published:February 14, 2018 Post category:BioPharma Janssen got a little love from the FDA on Wednesday. Source: BioSpace You Might Also Like John Wiley & Sons, Inc. Announces As New EVP Of Publishing Business October 12, 2017 Don't Stop Believing: Teva's R&D Head Gives 3 Reasons Why Investors Should Hold On November 15, 2017 Biogen Forges $278M MS Tie-Up With Alkermes November 26, 2017
